A Phase I/II Dose Escalation Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Transurethral Photodynamic Therapy With QLT0074 for Benign Prostatic Hyperplasia

Trial Profile

A Phase I/II Dose Escalation Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Transurethral Photodynamic Therapy With QLT0074 for Benign Prostatic Hyperplasia

Completed
Phase of Trial: Phase I/II

Latest Information Update: 22 May 2012

At a glance

  • Drugs Lemuteporfin (Primary)
  • Indications Benign prostatic hyperplasia
  • Focus Adverse reactions
  • Most Recent Events

    • 22 May 2012 Actual end date (May 2005) added as reported by ClinicalTrials.gov.
    • 22 May 2012 Actual initiation date (Mar 2003) added as reported by ClinicalTrials.gov.
    • 01 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top